As of September 2024, Neovacs has a market cap of $3.12M. This makes Neovacs the world's 35434th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.94B | 890000.00% |
2023 | $779.74K | -100.00% |
2022 | $131.00B | -99.92% |
2021 | $155.95T | -98.34% |
2020 | $9419.20T | -47.93% |
2019 | $18089.86T | -71.43% |
2018 | $63314.50T | -55.87% |
2017 | $143471.29T | -43.21% |
2016 | $252634.22T | -27.31% |
2015 | $347556.42T | -4.17% |
2014 | $362667.56T | 441599.27% |
2013 | $82.11T | -2.42% |
2012 | $84.14T | - |